Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
34 hedge funds and large institutions have $5.58M invested in Albireo Pharma Inc in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 5 closing their positions.
9% less call options, than puts
Call options by funds: $51K | Put options by funds: $56K
3% less funds holding
Funds holding: 35 → 34 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
22% less capital invested
Capital invested by funds: $7.19M → $5.58M (-$1.61M)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$430K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$133K |
| 3 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$99.8K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.6K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.96M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$1.3M |
| 3 |
O
OrbiMed
New York
|
-$279K |
| 4 |
FMA
FNY Managed Accounts
New York
|
-$214K |
| 5 |
Goldman Sachs
New York
|
-$121K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIM
26
BlackRock Investment Management
Wilmington,
Delaware
| $5K | +$1.01K | +24 | +21% |
|
27
UBS Group
Zurich,
Switzerland
| $3K | -$2.28K | -54 | -41% |
|
|
PMFA
28
Plante Moran Financial Advisors
Southfield,
Michigan
| $2K | – | – | – |
|
29
Bank of America
Charlotte,
North Carolina
| $1K | -$42 | -1 | -4% |
|
30
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
LTFS
31
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
32
William Blair & Company
Chicago,
Illinois
| – | -$1.3M | -12,369 | Closed |
|
|
O
33
OrbiMed
New York
| – | -$279K | -6,990 | Closed |
|
|
RCM
34
Rotella Capital Management
Bellevue,
Washington
| – | -$17K | -417 | Closed |
|
|
NPC
35
National Planning Corporation
El Segundo,
California
| – | -$3.63K | -83 | Closed |
|
36
Morgan Stanley
New York
| – | -$1.52K | -36 | -97% |
|
37
Citigroup
New York
| – | -$1K | -25 | Closed |
|
ALBO Hedge Fund Activity: Q1 2015 in Review
34 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2015, worth a combined $5.58M — down 22% from $7.19M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALBO and 4 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 7 added.
The largest buyer was Renaissance Technologies, adding an estimated $430K. The largest seller was Sabby Management, cutting an estimated $1.96M.
- 34 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2015, down from 35 in Q4 2014.
- Funds reported $5.58M of Albireo Pharma Inc stock for Q1 2015, down 22% quarter-over-quarter.
- 4 funds opened new Albireo Pharma Inc positions in Q1 2015 and 5 closed out, a net change of -1 holder.
- The largest Albireo Pharma Inc buyer in Q1 2015 was Renaissance Technologies, an estimated $430K added.
- The largest Albireo Pharma Inc seller in Q1 2015 was Sabby Management, an estimated $1.96M sold.
Based on aggregated 13F filings for Q1 2015.